Summary
- Current Price
- As of today, EOLS price is $6.37, up +14.16% on
- Current Price All-Time High
- EOLS price is currently -83.87% below its historical high of $39.50 set on
- Market Cap
- EOLS current market cap is $419M, down -43.96% year-over-year
- PE Ratio
- EOLS PE ratio is unknown
- Revenue
- EOLS current annual revenue is $297.18M, up +11.61% year-over-year
- Next Earnings
- As of today, the next earnings release for EOLS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Evolus, Inc. |
| Ticker | NASDAQ: EOLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evolus.com |
| Employees | 372 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.37 | |
| Price, 1D Change | +14.16% | |
| $419M | ||
| - | ||
| - | ||
| 1.31 | ||
| $297M | ||
| Revenue, 1Y Change | +11.61% | |
| -$0.80 | ||
| EPS, 1Y Change | +1.48% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.80 | ||
| EPS Estimate | N/A | -$0.12 |
| EPS Est. Change | N/A | +84.77% |
| $297.18M | ||
| Revenue Estimate | N/A | $329.96M |
| Revenue Est. Change | N/A | +11.03% |
| Current Price | $6.37 | |
| Price Target | - | $14.00 |
| Price Tgt. Change | - | +119.78% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.27 | -$0.81 | -201.67% | |
| -$0.45 | -$0.80 | -78.00% | |
| -$0.12 | N/A | +84.77% | |
| $0.24 | N/A | +129.71% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $266.10M | $266.27M | +0.07% | |
| $296.47M | $297.18M | +0.24% | |
| $329.96M | N/A | +11.03% | |
| $388.17M | N/A | +30.62% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.37 | |
| $6.11 | ||
| SMA 200 vs Price | -4.03% | |
| $4.77 | ||
| SMA 50 vs Price | -25.06% | |
| 1.31 | ||
| $0.34 | ||
| 77.63 | ||
| 76.12% | ||
| 70.90% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $297.18M | ||
| -$0.80 | ||
| $192.76M | ||
| 64.86% | ||
| -$37.60M | ||
| -12.65% | ||
| -$51.64M | ||
| -17.38% | ||
| -$28.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -6.71 | ||
| 1.90 | ||
| 1.54 | ||
| - | ||
| 2 | ||
| -1.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.39 | ||
| -4.34 | ||
| -24.96 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$23.11M | ||
| $53.83M | ||
| $225.87M | ||
| $142.92M | ||
| $248.97M | ||
| $75.31M | ||
| $155.00M | ||
| $2.53M | ||
| $23.36M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $348.82M | ||
| $230.36M | ||
| $104.41M | ||
| $0.00 | ||
| $8.74M | ||
| $0.00 | ||
| $677.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$42.27M | ||
| -$8.45M | ||
| $17.34M | ||
| $8.45M | ||
| -$50.72M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Mizuho | → | |
| BTIG | → | |
| Needham | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with EOLS
FAQ
What is the ticker symbol for Evolus, Inc.?
The ticker symbol for Evolus, Inc. is NASDAQ:EOLS
Does Evolus, Inc. pay dividends?
No, Evolus, Inc. does not pay dividends
What sector is Evolus, Inc. in?
Evolus, Inc. is in the Healthcare sector
What industry is Evolus, Inc. in?
Evolus, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Evolus, Inc. based in?
Evolus, Inc. is headquartered in United States
When did Evolus, Inc. go public?
Evolus, Inc. initial public offering (IPO) was on February 8, 2018
Is Evolus, Inc. in the S&P 500?
No, Evolus, Inc. is not included in the S&P 500 index
Is Evolus, Inc. in the NASDAQ 100?
No, Evolus, Inc. is not included in the NASDAQ 100 index
Is Evolus, Inc. in the Dow Jones?
No, Evolus, Inc. is not included in the Dow Jones index
When was Evolus, Inc. last earnings report?
Evolus, Inc.'s most recent earnings report was on May 4, 2026
When does Evolus, Inc. report earnings?
The date for Evolus, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EOLS Official Website www.evolus.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1570562/000162828026014001/0001628280-26-014001-index.htm
- EOLS Profile on Yahoo Finance finance.yahoo.com/quote/EOLS
- EOLS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/eols